152 related articles for article (PubMed ID: 32978662)
1. Does the number of laser applications for ROP treatment influence the degree of myopia?
Inoue T; Asaoka R; Hashimoto Y; Kitamoto K; Kitano M; Fujita A; Azuma K; Yamamoto K; Nagahara M; Kadonosono K; Obata R
Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):317-322. PubMed ID: 32978662
[TBL] [Abstract][Full Text] [Related]
2. Refractive Changes among Diode Laser-treated Retinopathy of Prematurity Patients: A Retrospective Study.
Alqurashi L; Alfaraidi A; Almahmoudi F; Danish E; Hadrawi M
Middle East Afr J Ophthalmol; 2023; 30(1):37-43. PubMed ID: 38435111
[TBL] [Abstract][Full Text] [Related]
3. Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes.
Katoch D; Sanghi G; Dogra MR; Beke N; Gupta A
Indian J Ophthalmol; 2011; 59(6):423-6. PubMed ID: 22011484
[TBL] [Abstract][Full Text] [Related]
4. Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?
Kıran Yenice E; Kara C
Int Ophthalmol; 2023 May; 43(5):1453-1458. PubMed ID: 36149616
[TBL] [Abstract][Full Text] [Related]
5. Investigating the factors affecting myopia in retinopathy of prematurity after laser treatment.
Asano S; Inoue T; Kure K; Kitano M; Fujita A; Nagahara M; Asaoka R; Obata R
Int J Retina Vitreous; 2023 Apr; 9(1):27. PubMed ID: 37046346
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
[TBL] [Abstract][Full Text] [Related]
7. Refractive and biometrical characteristics of children with retinopathy of prematurity who received laser photocoagulation or intravitreal ranibizumab injection.
Lu X; Zeng X; Chen M; Fan Z; Zheng L; Tian Y; Zhang S; He JC; Zhang G
Graefes Arch Clin Exp Ophthalmol; 2022 Oct; 260(10):3213-3219. PubMed ID: 35546637
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for early-onset high myopia after treatment for retinopathy of prematurity.
Matsumura S; Matsumoto T; Katayama Y; Tomita M; Morikawa H; Itokawa T; Kawakami M; Hori Y
Jpn J Ophthalmol; 2022 Jul; 66(4):386-393. PubMed ID: 35488107
[TBL] [Abstract][Full Text] [Related]
9. [Refraction and visual acuity after laser coagulation treatment for retinopathy of prematurity in stage 3+].
Récsán Z; Szamosi A; Karkó C; Vámos R; Sebestyén M; Fodor M; Salacz G
Ophthalmologe; 2004 Jan; 101(1):45-9. PubMed ID: 14872267
[TBL] [Abstract][Full Text] [Related]
10. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome.
Connolly BP; Ng EY; McNamara JA; Regillo CD; Vander JF; Tasman W
Ophthalmology; 2002 May; 109(5):936-41. PubMed ID: 11986101
[TBL] [Abstract][Full Text] [Related]
11. One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity.
Kıran Yenice E; Petriçli İS; Kara C
Int Ophthalmol; 2023 Jul; 43(7):2197-2202. PubMed ID: 36522564
[TBL] [Abstract][Full Text] [Related]
12. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy.
Kuo HK; Sun IT; Chung MY; Chen YH
Ophthalmologica; 2015; 234(4):211-7. PubMed ID: 26393895
[TBL] [Abstract][Full Text] [Related]
13. Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity.
Pawar N; Somyashree D; Meenakshi R; Maheshwari D; Mohideen S; Sithiq Uduman M
Indian J Ophthalmol; 2023 Jun; 71(6):2561-2568. PubMed ID: 37322680
[TBL] [Abstract][Full Text] [Related]
14. Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity.
McLoone EM; O'Keefe M; McLoone SF; Lanigan BM
J AAPOS; 2006 Oct; 10(5):454-9. PubMed ID: 17070482
[TBL] [Abstract][Full Text] [Related]
15. Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.
Chou YB; Wang AG; Yang HY; Chen KJ; Yang CS
Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3809-3816. PubMed ID: 35729410
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation.
Wiecek E; Akula JD; Vanderveen DK; Mantagos IS; Wu C; Curran AL; De Bruyn H; Peterson B; Fulton AB
Am J Ophthalmol; 2022 Aug; 240():252-259. PubMed ID: 35367438
[TBL] [Abstract][Full Text] [Related]
17. Refractive status of Chinese with laser-treated retinopathy of prematurity.
Ruan L; Shan HD; Liu XZ; Huang X
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S3-9. PubMed ID: 25756334
[TBL] [Abstract][Full Text] [Related]
18. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes.
Axer-Siegel R; Maharshak I; Snir M; Friling R; Ehrlich R; Sherf I; Shalev B; Sirota L; Weinberger D
Retina; 2008 Jun; 28(6):839-46. PubMed ID: 18536600
[TBL] [Abstract][Full Text] [Related]
19. Long-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age.
Yang CS; Wang AG; Shih YF; Hsu WM
Acta Ophthalmol; 2013 Jun; 91(4):e276-82. PubMed ID: 23601812
[TBL] [Abstract][Full Text] [Related]
20. One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.
Gunay M; Celik G; Ovali F; Yetik H; Aktas A; Gunay BO
Int Ophthalmol; 2015 Feb; 35(1):27-35. PubMed ID: 25381161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
